Valor neurosensation precision relief platform for diabetic neuropathy
The Valor NeuroSensation™ platform offers a customized oral and topical solution for painful diabetic peripheral neuropathy. It combines benfotiamine and ultramicronized palmitoylethanolamide with a topical component tailored to the user's symptoms, providing a targeted approach for effective pain management.
Overview
The Valor NeuroSensation Precision Relief Platform™ is designed to address painful diabetic peripheral neuropathy through a personalized, responder-matched system. It combines an oral module with a topical application, each selected based on the patient's specific sensory phenotype as indicated by the NTSS-6 assessment. This approach ensures that the treatment is tailored to the individual's predominant symptoms, such as burning, tingling, shooting pain, or nocturnal flares, enhancing the efficacy of pain management.
Technical specifications
- Oral Module: Utilizes clinically validated candidates like benfotiamine and ultramicronized palmitoylethanolamide, targeting metabolic and neuroimmune pathways.
- Topical Module: Features a film or hydrogel that offers rapid relief with minimal systemic exposure, chosen according to the patient's NTSS-6 sensory pattern.
- Adaptive System: Employs a safety screen to avoid use on compromised skin, and weekly NTSS-6 tracking to optimize treatment.
- Manufacturing: Supported by established oral/topical manufacturing processes, scalable for larger production.
Technology readiness level
The Valor NeuroSensation platform is currently at TRL 2, with ongoing development to refine product profiles, formulations, and regulatory strategies. Future phases will involve prototype production and small-scale feasibility studies to validate efficacy and safety before proceeding to commercialization.
About Valor Infrastructure Holdings, LLC
Valor Infrastructure Holdings, LLC is a patent licensing firm that focuses on developing and licensing intellectual property for critical infrastructure. The company specializes in four core architectural clusters: AI data center thermal infrastructure, acoustic medical platform technology, atmospheric filtration, and infrastructure safety systems. Operating under a pure-licensing model, Valor designs and files foundational US patents, allowing industrial partners to manage the manufacturing, distribution, and deployment of the resulting technologies. Their approach centers on the creation of robust patent architectures that address technical challenges in efficiency, safety, and environmental control.
By licensing these architectures, Valor enables industry leaders to implement advanced systems such as phononic-crystal atmospheric filtration for hospitals, self-stabilizing infrastructure control surfaces, and acoustic-based water purification. These solutions are designed to integrate with modern networks, such as smart-hospital management systems, offering alternatives to traditional filter media or chemical-heavy processes. The company emphasizes a commitment to long-term intellectual property foundations as a means to foster innovation in complex infrastructure environments.
delivered to your inbox.